Bank of New York Mellon
HURA

Bank of New York Mellon’s TuHURA Biosciences HURA Stock Holding History

Bank of New York Mellon’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
121,662
-89,906
-42% -$209K ﹤0.01% 4030
2026
Q1 		$379K Buy
211,568
+1,166
+0.6% +$1.43K ﹤0.01% 3728
2025
Q4 		$159K Buy
210,402
+13,096
+7% +$25.1K ﹤0.01% 4065
2025
Q3 		$489K Sell
197,306
-54,803
-22% -$144K ﹤0.01% 3603
2025
Q2 		$562K Buy
+252,109
New +$852K ﹤0.01% 3446

Other funds holding HURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $481M AUM 20.5% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's HURA Position: Q2 2026 in Review

Bank of New York Mellon reduced its TuHURA Biosciences (HURA) stake by 42% in Q2 2026, selling an estimated $209K and leaving 121,662 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

Bank of New York Mellon first reported a position in HURA in Q2 2025 and has held it in 5 quarters since. The position peaked at $562K in Q2 2025. 42 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Bank of New York Mellon held 121,662 shares of TuHURA Biosciences worth $285K as of Q2 2026.
  • Bank of New York Mellon sold 89,906 TuHURA Biosciences shares in Q2 2026, an estimated $209K.
  • TuHURA Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4030 holding.
  • Bank of New York Mellon first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Bank of New York Mellon's TuHURA Biosciences position peaked at $562K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.